Printer Friendly
The Free Library
5,666,863 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Opening of EuroBiO 2006 International Congress of Biotechnologies.


Today, Wednesday, October 25th, at the "Palais des CongrE s" Conference Center in Paris

PARIS -- EuroBiO 2006 (www.eurobio2006.com) opens today, Wednesday October 25th, for three days - Wednesday 25th, Thursday 26th and Friday 27th October, at the "Palais des CongrE s" conference center in Paris.

EuroBiO, international platform of the biotechnology world, is the place where the trends and news in the bio-industry are presented and discussed with a primary focus on European European

emanating from or pertaining to Europe.


European bat lyssavirus
see lyssavirus.

European beech tree
fagussylvaticus.

European blastomycosis
see cryptococcosis.
 problems.

Each of the three days will deal with a specific theme via a rich programme of conferences, symposia sym·po·si·a  
n.
A plural of symposium.
, round tables and plenary sessions Plenary session is a term often used in s to define the part of the conference when all members of all parties are in attendance.

These sessions may contain a broad range of content from Keynotes to Panel Discussions and are not necessarily related to a specific style of delivery.
: Innovation day on Wednesday, Finance day on Thursday, Global Issues day on Friday.

International experts from the fields of science Fields of science are widely-recognized categories of specialized expertise within science, and typically embody their own terminology and nomenclature.

Natural sciences

Main article: Natural science
, industry and finance who will expose, debate and contribute to highlighting the advances, needs, trends and impacts of biotechnologies in its four main fields of use: industry, health, environment and food sectors. They will also help us to better understand the new fields of use for biotechnologies and the issues associated with them.

EuroBiO 2006, under the title of: Europe of Clusters - or centres of excellence - is organised around four axes axes

[L., Gr.] plural of axis. The straight lines which intersect at right angles and on which graphs are drawn. Usually the horizontal axis is the x-axis and the vertical one the y-axis. Called also axes of reference.
: a conference with plenary sessions, round tables and symposia with almost 200 international contributors; a business convention that facilitates meetings and networking amongst 500 companies; an exhibition bringing together international centres of excellence, companies and consultancies that are leaders in their sector; and a career fair to make it easier for companies and jobseekers to make contact with each other.

EuroBiO 2006 is a superb occasion to learn, meet and debate with experts and journalists on research and innovation, finance and industries in the field of biotechnology. What are the new energy sources available today? How will biotechnologies help in better protecting our environment? What are green chemistry, biomaterials, new medicines, bio-ethics, stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young , Jeune Entreprise Innovante (young innovating company), sources of finance for companies, available grants, centres of excellence? Just some of the questions for which you can find answers at EuroBiO 2006.

EuroBiO 2006 will highlight the biotech bi·o·tech  
n. Informal
Biotechnology.


biotech
Noun

short for biotechnology

Noun 1.
 industry's key sectors & issues by bringing together:

* More than 4,000 professionals from the biotechnology industry.

* 200 international speakers

* 500 leading companies & service providers

* National and international bioclusters

* Federations and industry bodies

* Multinationals

* International delegations from 16 countries

* Research organizations from around the world

* Patient associations

About EuroBiO

In 2006, the European Biotech Crossroads will take place in Paris for its 10th anniversary and will adopt the name "EuroBiO".

EuroBiO is an international event, with a prime focus on European issues and dedicated to biotech's four major fields of application - industry, health, environment and food sectors.

Founded in 1997 on the initiative of the French Ministry of Research, the European Biotech Crossroads has succeeded in bringing together all the biotechnology actors: life science companies, start-up Start-up

The earliest stage of a new business venture.
 projects, students, researchers, private & public-sector research organizations, industry bodies, investors, consulting firms Noun 1. consulting firm - a firm of experts providing professional advice to an organization for a fee
consulting company

business firm, firm, house - the members of a business organization that owns or operates one or more establishments; "he worked for a
, multinationals from the biotech, pharmaceutical, diagnostics, agrifood & environmental sectors, local authorities, clusters, bioparks, bioincubators, public authorities and regulatory bodies.

Organization of the European Biotech Crossroads was attributed to (i) the city of Lille and the EurasantE[umlaut umlaut (m`lout) [Ger.,=transformed sound], in inflection, variation of vowels of the type of English man to men. ] cluster for the 2005 edition and the odd-numbered years to come and (ii) Paris, its Regional Economic Development Agency for Paris Ile-de-France (ARD Ard (ärd), in the Bible.

1 Son of Benjamin.

2 Benjamite, perhaps the same as (1.) An alternate form is Addar.
) and their partners for the even-numbered years from 2006 on.

For more detailed information, visit the EuroBiO 2006 web site at: www.eurobio2006.com
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 25, 2006
Words:560
Previous Article:Elan Reports Third Quarter 2006 Financial Results.
Next Article:Fast Search & Transfer Announces Q3 2006 Results.
Topics:



Related Articles
Senators, members of Congress and former first lady decry stem cell policy.(The Church and State)
Simplified sensor technology advances to commercialization.
Olympus, Cangen Biotechnologies to Expand Joint Development of Molecular Diagnostic Test for Early Lung Cancer Detection.
Lifeline Biotechnologies, Inc. Initiates Latin American MastaScope(TM) Sales Effort.
Lifeline Biotechnologies, Inc. Reduces Outstanding Debt by $300,000.
Lifeline Biotechnologies Welcomes Dr. Pedro Escobar to Its Medical Advisory Board.
New Zealand ''New Thinking'' Leads Next Wave of Biotechnology Innovation; Industry and Governmental Delegation to BIO 2006 Highlights Strong Science...
Lifeline Biotechnologies Receives $27,000 Order from Chinese Distributor for the MastaScope(TM).
Millennium Biotechnologies' Announces The Acceptance and Presentation of a SOD/gliadin Study In AIDS by the International AIDS Society.
Thomas Matthes Joins Sloning Biotechnology as Chief Business Officer to Drive Global Sales and Marketing Activities for Sloning's Gene Synthesis...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles